Dyslipidemia is a major contributor to cardiovascular disease, yet many patients remain undermanaged due to evolving guidelines and care complexities. Health care professionals need targeted education to improve risk assessment, apply evidence-based therapies, and personalized treatment. This program addresses these gaps, helping clinicians optimize lipid management and improve cardiovascular outcomes.
Nonmember Pricing: $295 | Informed Member - $235 | Engaged Member - $175 | Fellows $115 (AACE Membership Required)
Institutional Pricing and Group Discounts (5+ licenses) are available for AACE Certificate Courses.
9/3/2025
9/3/2027
At the end of this activity, participants will be able to:
- Assess and calculate atherosclerotic cardiovascular disease (ASCVD) risk for patients with dyslipidemia, establishing individualized lipid goals based on patient demographics, comorbidities, and guideline-recommended targets.
- Develop evidence-based treatment plans for dyslipidemia incorporating lifestyle modifications and pharmacological therapies, using shared decision-making to counsel patients on dietary interventions, exercise, and other modifiable risk factors.
- Apply knowledge of pharmacotherapy options and emerging treatments in clinical scenarios, adjusting management strategies based on patient response, statin intolerance, or contraindications.
- Develop individualized dyslipidemia management strategies for special populations, such as patients with diabetes, severe hypertriglyceridemia (HTG), chronic kidney disease (CKD), and post-transplant.
- Address clinical challenges like statin intolerance and severe HTG by applying evidence-based guidelines to optimize treatment outcomes and minimize adverse effects.
The primary target audience includes Nurse Practitioners, Physician Assistants, Pharmacists. The secondary target audience is Endocrinologists and Other Clinicians who treat endocrine conditions.
Physician Credit
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Endocrinology (ACE) designates enduring activity for a maximum of 6 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
Provider approved by the California Board of Registered Nursing, Provider Number 17762, for 6 contact hours.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.
Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.
Thank you to our faculty for developing this certificate:
Tori Calder, DNP, AGNP-BC, CDCES
Senior Nurse Practitioner, Northwell Health
Division of Diabetes, Endocrinology & Metabolism
Samaneh Dowlatshahi, MD, FACP, FACE
Houston Methodist Hospital
Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP
Endocrine Clinical Pharmacy Specialist
Cleveland Clinic Diabetes Center
Daniya Matthew, PharmD
Northwell Health
David Myers, DNP, ANP
Nurse Practitioner, Northwell Health